Contribute Try STAT+ Today

President Trump’s interview this week with the New York Times made headlines for his revelation that he would never have chosen Jeff Sessions as attorney general if he had known Sessions would recuse himself from the Russia investigation. Here at STAT, however, we combed through the transcript of the Oval Office interview for something else: examples of the emotional subtexts that psychiatrists and psychologists told us offer a window into the president’s mind.

Overall, Trump was more articulate than he has been in some recent appearances, an important reminder than his tortured syntax might reflect not mental decline but emotional stress: He seemed comfortable with the reporters. Nevertheless, the workings of Trump’s mind, as inferred by experts who have described their observations to STAT since January, shone through. “Most of the now-familiar Trumpian patterns are here,” said psychologist John Montgomery of New York University. Among them:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.